TickerFactsScreenerDevelopers

GYRE THERAPEUTICS, INC. (GYRE) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2022: $4.79M2023: $4.64M2024: $3.88M2025: $5.42M$5.42M
2022Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$5.42M+39.4%
2024$3.88M-16.2%
2023$4.64M-3.3%
2022$4.79M—